Jane Street
HCWB icon

Jane Street’s HCW Biologics HCWB Stock Holding History

Jane Street’s Portfolio HCWB Stock Details HCWB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.09K Buy
+2,356
New +$12.2K ﹤0.01% 11354
2024
Q3 		– Sell
-101
Closed -$15.6K – 9900
2024
Q2 		$15.6K Buy
101
+29
+40% +$8.57K ﹤0.01% 9062
2024
Q1 		$30.2K Buy
+72
New +$23K ﹤0.01% 8840

Other funds holding HCWB

HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
GSWM
Golden State Wealth Management Santa Ana, California $1.1B AUM 27.49% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Jane Street's HCWB Position: Q1 2026 in Review

Jane Street opened a new position in HCW Biologics (HCWB) in Q1 2026: 2,356 shares worth $5.09K. The stake represents ﹤0.01% of the portfolio and ranks #11354 among its holdings. This is a return to the name: Jane Street previously reported a position in HCWB as recently as Q2 2024.

Jane Street first reported a position in HCWB in Q1 2024 and has held it in 3 quarters since. The position peaked at $30.2K in Q1 2024. 13 funds tracked by Wall St. Rank hold HCWB as of Q1 2026.

  • Jane Street held 2,356 shares of HCW Biologics worth $5.09K as of Q1 2026.
  • HCW Biologics was a new Jane Street position in Q1 2026.
  • HCW Biologics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #11354 holding.
  • Jane Street first reported a position in HCW Biologics in Q1 2024 and has held it in 3 quarters since.
  • Jane Street's HCW Biologics position peaked at $30.2K in Q1 2024.
  • 13 funds tracked by Wall St. Rank held HCW Biologics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.